AIkido Pharma (AIKI) Competitors $4.60 +0.07 (+1.55%) As of 04/24/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsInsider TradesSEC FilingsTrendsBuy This Stock AIKI vs. NOTV, ONMD, LUNA, BIAF, ISPC, DKDCA, IQV, INCY, ICLR, and MEDPShould you be buying AIkido Pharma stock or one of its competitors? The main competitors of AIkido Pharma include Inotiv (NOTV), OneMedNet (ONMD), Luna Innovations (LUNA), bioAffinity Technologies (BIAF), iSpecimen (ISPC), Data Knights Acquisition (DKDCA), IQVIA (IQV), Incyte (INCY), ICON Public (ICLR), and Medpace (MEDP). These companies are all part of the "commercial physical research" industry. AIkido Pharma vs. Inotiv OneMedNet Luna Innovations bioAffinity Technologies iSpecimen Data Knights Acquisition IQVIA Incyte ICON Public Medpace Inotiv (NASDAQ:NOTV) and AIkido Pharma (NASDAQ:AIKI) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their community ranking, profitability, analyst recommendations, media sentiment, earnings, institutional ownership, dividends, valuation and risk. Is NOTV or AIKI more profitable? AIkido Pharma has a net margin of 0.00% compared to Inotiv's net margin of -25.40%. Inotiv's return on equity of -15.41% beat AIkido Pharma's return on equity.Company Net Margins Return on Equity Return on Assets Inotiv-25.40% -15.41% -3.58% AIkido Pharma N/A -18.21%-16.94% Does the MarketBeat Community favor NOTV or AIKI? AIkido Pharma received 82 more outperform votes than Inotiv when rated by MarketBeat users. Likewise, 63.92% of users gave AIkido Pharma an outperform vote while only 48.72% of users gave Inotiv an outperform vote. CompanyUnderperformOutperformInotivOutperform Votes1948.72% Underperform Votes2051.28% AIkido PharmaOutperform Votes10163.92% Underperform Votes5736.08% Which has more volatility & risk, NOTV or AIKI? Inotiv has a beta of 3.96, suggesting that its share price is 296% more volatile than the S&P 500. Comparatively, AIkido Pharma has a beta of 0.93, suggesting that its share price is 7% less volatile than the S&P 500. Do insiders and institutionals have more ownership in NOTV or AIKI? 18.2% of Inotiv shares are owned by institutional investors. Comparatively, 10.9% of AIkido Pharma shares are owned by institutional investors. 7.8% of Inotiv shares are owned by company insiders. Comparatively, 8.6% of AIkido Pharma shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Do analysts prefer NOTV or AIKI? Inotiv presently has a consensus price target of $5.92, suggesting a potential upside of 216.40%. Given Inotiv's stronger consensus rating and higher probable upside, analysts plainly believe Inotiv is more favorable than AIkido Pharma.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Inotiv 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.67AIkido Pharma 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has better earnings and valuation, NOTV or AIKI? AIkido Pharma has lower revenue, but higher earnings than Inotiv. AIkido Pharma is trading at a lower price-to-earnings ratio than Inotiv, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioInotiv$475.11M0.13-$108.44M-$4.61-0.41AIkido Pharma$10K2,523.10-$7.17M-$3.88-1.19 Does the media refer more to NOTV or AIKI? In the previous week, Inotiv had 2 more articles in the media than AIkido Pharma. MarketBeat recorded 2 mentions for Inotiv and 0 mentions for AIkido Pharma. Inotiv's average media sentiment score of 0.93 beat AIkido Pharma's score of 0.00 indicating that Inotiv is being referred to more favorably in the media. Company Overall Sentiment Inotiv Positive AIkido Pharma Neutral SummaryInotiv beats AIkido Pharma on 11 of the 18 factors compared between the two stocks. Get AIkido Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for AIKI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AIKI vs. The Competition Export to ExcelMetricAIkido PharmaCommercial physical research IndustryMedical SectorNASDAQ ExchangeMarket Cap$25.23M$2.99B$5.44B$7.80BDividend YieldN/A2.83%5.43%4.31%P/E Ratio-1.1987.7522.1418.40Price / Sales2,523.10138.59389.71101.29Price / CashN/A34.5738.2034.62Price / Book0.242.336.664.18Net Income-$7.17M$113.28M$3.21B$247.71M7 Day Performance15.29%2.14%6.21%6.61%1 Month Performance-16.21%14.68%-2.82%-2.21%1 Year Performance70.37%-1.57%16.44%4.68% AIkido Pharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AIKIAIkido PharmaN/A$4.60+1.5%N/A+66.7%$25.23M$10,000.00-1.194High Trading VolumeNOTVInotiv1.5427 of 5 stars$1.66+3.1%$5.92+256.4%-56.4%$55.97M$475.11M-0.362,100Positive NewsGap UpONMDOneMedNet0.7704 of 5 stars$0.45-1.0%N/A-31.6%$13.87M$957,651.00-1.252Gap DownLUNALuna Innovations1.5972 of 5 stars$0.40+33.3%$8.00+1,900.0%-83.9%$13.58M$116.61M0.00390Analyst ForecastGap UpBIAFbioAffinity Technologies2.615 of 5 stars$0.50-0.1%$6.00+1,109.7%-79.3%$9.05M$9.36M-0.6010ISPCiSpecimen1.4048 of 5 stars$1.22+3.0%N/A+346.1%$3.03M$9.29M-0.0660Negative NewsDKDCAData Knights AcquisitionN/A$0.45-4.3%N/A-33.9%$2.33MN/A-2.372High Trading VolumeIQVIQVIA4.9157 of 5 stars$143.33+1.5%$241.50+68.5%-35.8%$25.21B$15.41B19.0786,000Analyst DowngradeGap DownINCYIncyte4.8706 of 5 stars$57.52+1.3%$74.69+29.8%+15.6%$11.14B$4.24B213.272,320Upcoming EarningsICLRICON Public4.0179 of 5 stars$137.51+0.2%$232.67+69.2%-51.7%$11.10B$8.28B14.4241,100Upcoming EarningsMEDPMedpace4.4316 of 5 stars$273.29-5.4%$357.50+30.8%-23.4%$8.29B$2.11B21.705,200Earnings ReportAnalyst ForecastAnalyst RevisionNews CoverageHigh Trading Volume Related Companies and Tools Related Companies Inotiv Alternatives OneMedNet Alternatives Luna Innovations Alternatives bioAffinity Technologies Alternatives iSpecimen Alternatives Data Knights Acquisition Alternatives IQVIA Alternatives Incyte Alternatives ICON Public Alternatives Medpace Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:AIKI) was last updated on 4/26/2025 by MarketBeat.com Staff From Our PartnersDonald Trump is about to free crypto from its chains …Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election...Weiss Ratings | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump’s tariffs just split the AI market in twoTrump’s tariff just split the AI market – among others – in two. One group of AI companies—the ones relying...Traders Agency | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | SponsoredIt’s absolute chaos in Silicon Valley right now…If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk...Brownstone Research | SponsoredTrump’s treachery Forget what the media tells you. Trump’s inner circle may be pushing a financial reset that mirrors moves from...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AIkido Pharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AIkido Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy AIKI Stock Free AIKI Stock Alerts